Fetal Aneuploidy clinical trials at UCSD
1 research study open to eligible people
Showing trials for
Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
open to eligible females ages 18 years and up
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
San Diego, California and other locations
Our lead scientists for Fetal Aneuploidy research studies include Andrew Hull, MD.